| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Keybanc analyst Matthew Gillmor maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Overweight and lowers the price target f...
RBC Capital analyst Ben Hendrix maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Outperform and lowers the price target f...
Guggenheim analyst Jason Cassorla maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $...
UBS analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $31 to $28.
Cantor Fitzgerald analyst Sarah James maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and lowers the price targe...
Barclays analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Equal-Weight and lowers the price target fro...
On October 30, 2025, Dr. Nasser Khan notified the Company of his resignation as Chief Operating Officer ("COO") of the ...